BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16803534)

  • 1. Combined E-cadherin, alpha-catenin, and beta-catenin expression is a favorable prognostic factor in endometrial carcinoma.
    Scholten AN; Aliredjo R; Creutzberg CL; Smit VT
    Int J Gynecol Cancer; 2006; 16(3):1379-85. PubMed ID: 16803534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.
    Kim YT; Choi EK; Kim JW; Kim DK; Kim SH; Yang WI
    Yonsei Med J; 2002 Dec; 43(6):701-11. PubMed ID: 12497652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
    Schlosshauer PW; Ellenson LH; Soslow RA
    Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
    Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-cadherin and β-catenin immunoexpression in endometrioid endometrial carcinoma.
    Florescu MM; Pirici D; Simionescu CE; Stepan AE; Mărgăritescu C; Tudorache Ş; Ciurea RN
    Rom J Morphol Embryol; 2016; 57(4):1235-1240. PubMed ID: 28174789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: role in formation of metastasis.
    Czyzewska J; Guzińska-Ustymowicz K; Ustymowicz M; Pryczynicz A; Kemona A
    Folia Histochem Cytobiol; 2010 Jan; 48(1):37-45. PubMed ID: 20529814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor budding and E-Cadherin expression in endometrial carcinoma: are they prognostic factors in endometrial cancer?
    Koyuncuoglu M; Okyay E; Saatli B; Olgan S; Akin M; Saygili U
    Gynecol Oncol; 2012 Apr; 125(1):208-13. PubMed ID: 22198340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome.
    Goyal A; Martin TA; Mansel RE; Jiang WG
    World J Surg Oncol; 2008 Jun; 6():56. PubMed ID: 18547424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune expression of E-cadherin and α, β and γ-Catenin adhesion molecules and prognosis for upper urinary tract urothelial carcinomas.
    Reis ST; Leite KR; Mosconi Neto A; Pontes Júnior J; Viana NI; Antunes AA; Dall'Oglio MF; Srougi M
    Int Braz J Urol; 2012; 38(4):466-73. PubMed ID: 22951176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast.
    Kuroda H; Tamaru J; Takeuchi I; Ohnisi K; Sakamoto G; Adachi A; Kaneko K; Itoyama S
    Virchows Arch; 2006 Apr; 448(4):500-5. PubMed ID: 16538444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of E-cadherin and alpha-,beta- and gamma-catenins in human bladder carcinomas: are they good prognostic factors?
    Mialhe A; Louis J; Montlevier S; Peoch M; Pasquier D; Bosson JL; Rambeaud JJ; Seigneurin D
    Invasion Metastasis; 1997; 17(3):124-37. PubMed ID: 9702939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia.
    Moreno-Bueno G; Hardisson D; Sarrió D; Sánchez C; Cassia R; Prat J; Herman JG; Esteller M; Matías-Guiu X; Palacios J
    J Pathol; 2003 Apr; 199(4):471-8. PubMed ID: 12635138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical expression of the E-cadherin-catenin complex in gastric cancer].
    Guzmán P; Araya J; Villaseca M; Roa I; Melo A; Muñoz S; Roa J
    Rev Med Chil; 2006 Aug; 134(8):1002-9. PubMed ID: 17130988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma: a prospective immunocytochemical study.
    Athanassiadou P; Athanassiades P; Grapsa D; Gonidi M; Athanassiadou AM; Stamati PN; Patsouris E
    Int J Gynecol Cancer; 2007; 17(3):697-704. PubMed ID: 17504383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-cadherin expression in breast carcinoma indicates poor survival.
    Peralta Soler A; Knudsen KA; Salazar H; Han AC; Keshgegian AA
    Cancer; 1999 Oct; 86(7):1263-72. PubMed ID: 10506713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
    Kashibuchi K; Tomita K; Schalken JA; Kume H; Yamaguchi T; Muto S; Horie S; Kitamura T
    Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression.
    Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I
    Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer.
    Stefansson IM; Salvesen HB; Akslen LA
    J Clin Oncol; 2004 Apr; 22(7):1242-52. PubMed ID: 15051772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
    Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
    Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of hypoxia-inducible factor 1α, TWIST and E-cadherin is associated with aggressive tumor phenotypes in endometrioid endometrial carcinoma.
    Feng Z; Gan H; Cai Z; Li N; Yang Z; Lu G; Chen J
    Jpn J Clin Oncol; 2013 Apr; 43(4):396-403. PubMed ID: 23372184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.